Stock Scorecard



Stock Summary for Mckesson Corporation (MCK) - $805.37 as of 12/3/2025 8:32:40 PM EST

Total Score

16 out of 30

Safety Score

56 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for MCK

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MCK

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MCK

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MCK

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MCK (56 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 6
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for MCK

McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025 12/4/2025 12:00:00 AM
Why Cencora (COR) Shares Are Trading Lower Today 12/3/2025 3:26:00 PM
How Is Cencora’s Stock Performance Compared to Other Medical Stocks? 12/3/2025 8:35:00 AM
McKesson Corporation pushes for biopharma collaboration in cancer care 12/3/2025 2:52:00 AM
What Recent Specialty Pharma Moves Mean for Cardinal Health’s Stock Valuation 12/2/2025 12:00:00 AM
McKesson’s Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care 12/1/2025 4:06:00 PM
McKesson’s Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care 12/1/2025 1:00:00 PM
Is There Opportunity in Henry Schein After 18% Rally and Digital Dentistry Expansion? 12/1/2025 12:00:00 AM
McKesson’s Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care 12/1/2025 12:00:00 AM
Is McKesson Corporation Stock Outperforming the S&P 500? 11/28/2025 12:13:00 AM

Financial Details for MCK

Company Overview

Ticker MCK
Company Name Mckesson Corporation
Country USA
Description McKesson Corporation (MCK) is a leading force in the U.S. healthcare sector, primarily engaged in the distribution of pharmaceuticals and medical supplies while offering comprehensive healthcare management solutions. By harnessing cutting-edge technology and a diverse service portfolio, McKesson drives operational efficiencies for healthcare providers, payers, and pharmaceutical partners. The company's commitment to innovation not only bolsters its competitive positioning but also enhances patient outcomes and streamlines healthcare delivery. As a pivotal player in the dynamic healthcare ecosystem, McKesson is dedicated to advancing a more efficient and patient-focused healthcare landscape.
Sector Name HEALTHCARE
Industry Name MEDICAL DISTRIBUTION
Most Recent Quarter 9/30/2025
Next Earnings Date 2/4/2026

Stock Price History

Last Day Price 805.37
Price 4 Years Ago 243.49
Last Day Price Updated 12/3/2025 8:32:40 PM EST
Last Day Volume 1,476,776
Average Daily Volume 708,469
52-Week High 894.75
52-Week Low 555.78
Last Price to 52 Week Low 44.91%

Valuation Measures

Trailing PE 27.55
Industry PE 27.71
Sector PE 88.06
5-Year Average PE 21.70
Free Cash Flow Ratio 24.19
Industry Free Cash Flow Ratio 33.19
Sector Free Cash Flow Ratio 28.78
Current Ratio Most Recent Quarter 0.88
Total Cash Per Share 33.29
Book Value Per Share Most Recent Quarter -14.02
Price to Book Ratio 5.04
Industry Price to Book Ratio 7.91
Sector Price to Book Ratio 33.12
Price to Sales Ratio Twelve Trailing Months 0.28
Industry Price to Sales Ratio Twelve Trailing Months 0.40
Sector Price to Sales Ratio Twelve Trailing Months 15.97
Analyst Buy Ratings 10
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 123,427,000
Market Capitalization 99,404,402,990
Institutional Ownership 90.69%

Dividends

Ex-Dividend Date 12/1/2025
Previous Dividend Amount 0.8200
Current Dividend Amount 0.8200
Total Years Dividend Increasing Dividend Contender - Increasing for 17 Years
Trailing Annual Dividend Rate 3.06
Trailing Annual Dividend Yield 0.35%
Forward Annual Dividend Rate 3.28
Forward Annual Dividend Yield 0.37%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 0.49%
5-Year Average Dividend Yield 0.56%
1-Year Dividend Growth Rate Percentage 15.04%
3-Year Dividend Growth Rate Percentage 14.85%
5-Year Dividend Growth Rate Percentage 14.51%
All-Time Dividend Growth Rate Percentage 4.05%
Dividend Payout Ratio 9.57%

Income Statement

Quarterly Earnings Growth YOY 377.00%
Annual Earnings Growth 9.76%
Reported EPS 12 Trailing Months 31.98
Reported EPS Past Year 18.12
Reported EPS Prior Year 33.10
Net Income Twelve Trailing Months 4,033,000,000
Net Income Past Year 3,295,000,000
Net Income Prior Year 3,002,000,000
Quarterly Revenue Growth YOY 10.10%
5-Year Revenue Growth 9.22%
Operating Margin Twelve Trailing Months 1.37%

Balance Sheet

Total Cash Most Recent Quarter 4,109,000,000
Total Cash Past Year 5,691,000,000
Total Cash Prior Year 4,583,000,000
Net Cash Position Most Recent Quarter -1,902,000,000
Net Cash Position Past Year 1,228,000,000
Long Term Debt Past Year 4,463,000,000
Long Term Debt Prior Year 5,579,000,000
Total Debt Most Recent Quarter 6,011,000,000
Equity to Debt Ratio Past Year -0.87
Equity to Debt Ratio Most Recent Quarter -0.41
Total Stockholder Equity Past Year -2,074,000,000
Total Stockholder Equity Prior Year -1,971,000,000
Total Stockholder Equity Most Recent Quarter -1,739,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 6,171,000,000
Free Cash Flow Per Share Twelve Trailing Months 50.00
Free Cash Flow Past Year 5,226,000,000
Free Cash Flow Prior Year 3,627,000,000

Options

Put/Call Ratio 0.34
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 22.17
MACD Signal 22.19
20-Day Bollinger Lower Band 616.55
20-Day Bollinger Middle Band 758.31
20-Day Bollinger Upper Band 900.07
Beta 0.39
RSI 63.42
50-Day SMA 693.78
150-Day SMA 546.38
200-Day SMA 492.74

System

Modified 12/2/2025 3:49:08 AM EST